Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer.

L Qiu, H Tan, H Yin, J Zhou, D Cheng… - The Quarterly Journal of …, 2018 - europepmc.org
Background The aim was to compare the detect ability of three sequential 131I whole-body
scans (tri-WBS) on the second, third, and fourth day after 131I therapy for metastatic thyroid …

Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancer

A Chong, HC Song, JJ Min, SY Jeong, JM Ha… - Nuclear medicine and …, 2010 - Springer
Purpose The purpose of this study is to compare post-therapy third day and seventh day I-
131 whole body scans (3DWBS and 7DWBS) in detecting lung or bone metastasis from well …

Utility of additional delayed post-therapeutic 131I whole-body scanning in patients with thyroid cancer

N Kodani, C Okuyama, N Aibe… - Clinical nuclear …, 2012 - journals.lww.com
Objective: The purpose of this study is to compare early (3 days after administration) and
delayed (7–9 days after administration) post-therapeutic 131 I scanning for detecting …

The comparison of 131I whole-body scans on the third and tenth day after 131I therapy in patients with well-differentiated thyroid cancer: preliminary report

JW Lee, SM Lee, GP Koh, DH Lee - Annals of nuclear medicine, 2011 - Springer
Objective The purpose of the present study was to evaluate the clinical usefulness of the
delayed post-therapeutic 131 I scan in patients with well-differentiated thyroid cancer by …

A comparison of the effectiveness of 131I whole body scans and plasma Tg determinations in the diagnosis of metastatic differentiated carcinoma of the thyroid: a …

M Hüfner, HP Stumpf, M Grussendorf… - European Journal of …, 1983 - academic.oup.com
In 68 patients with proved metastases of differentiated thyroid carcinoma the comparative
value of the 131I whole body scan and plasma Tg measurements in establishing the …

[HTML][HTML] Clinical significance of discordant findings between pre-therapy 123I and post-therapy 131I whole body scan in patients with thyroid cancer

PE Bravo, B Goudarzi, U Rana… - … journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Radioactive therapy with 131 I (RAI) is commonly used during the management of patients
with differentiated thyroid cancer (DTC). The aim of this study was to determine the clinical …

Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: predictive value and recommendations

Y Tachi, S Iwano, K Kato, M Tadokoro… - Clinical nuclear …, 2008 - journals.lww.com
Methods: We undertook a retrospective review of records of 42 patients (28 women and 14
men, mean age 52.7 years). The patients had received 62 rounds of I-131 therapy for lung …

Value of post-therapy whole-body 131I scan in the evaluation of patients with differentiated thyroid cancer

R Tian, A Kuang, W Qin, H Zhang - Chinese Journal of Nuclear …, 2000 - inis.iaea.org
[en] Objective: To evaluate the application of posttreatment whole body 131 I scan in
detecting metastasis lesions that were not detected on the whole body scan with 185 MBq of …

[HTML][HTML] A semiquantitative study of the optimal whole-body imaging time after 131I therapy for differentiated thyroid cancer

S Liu, R Zuo, T Yang, H Pang, Z Wang - Frontiers in Endocrinology, 2022 - frontiersin.org
Objective We compared the efficacy of post-therapy whole-body scintigraphy (Tx-WBS) in
terms of detecting lesions in patients with differentiated thyroid cancer (DTC) on days 3, 7 …

Frequency of diagnostic dilemmas in 131I whole body scanning

TH Leitha, A Staudenherz - Nuklearmedizin-NuclearMedicine, 2003 - thieme-connect.com
Aim: The specific excretion pathways of iodine may cause several diagnostic pitfalls.
Information concerning their relative frequency and possible consequences in daily routine …